der Reise ...Eine Deutsche Firma hat jetzt das sagen bei Ivax ,wenn die 75c pro Aktie bezahlen dann ist mit sicherheit noch mehr drin vor allem wenn die Zulassung da ist.
http://southflorida.bizjournals.com/southflorida/...26.html?ana=yfcpcA German company has purchased most of the outstanding stock of Miami-based Ivax Diagnostics in a $15 million deal.
The local company (AMEX: IVD) makes and distributes in vitro diagnostic kits, as does its controlling shareholder, Erba Diagnostics Mannheim. The German company purchased all of the shares controlled by Patrice Debregeas and Paul Kennedy – about 72 percent of the company’s common stock. It paid 75 cents a share.
Debregeas is the chairman of Ivax Diagnostics. Kennedy is on its board and was once its president and CEO.
It appears that the pair made a profit on the sale to Erba. In September 2008, Kennedy and Debregeas paid $14 million, or 70 cents a share, to acquire 72 percent of Ivax Diagnostics from Teva Pharmaceutical Industries.
Company officials declined to comment further.
Ivax Diagnostics recently reported a loss of $1.3 million on revenue of $2.3 million in the second quarter.
According to Erba’s website, it markets its products in 50 countries in Latin America, Europe, Africa and Asia. It does not mention distribution in the U.S.
Ivax Diagnostics shares were up 8 cents, or nearly 15 percent, to 63 cents in midday trading. The 52-week high was 80 cents on April 13. The 52-week low was 41 cents on Jan. 4.
Read more: German company gains control of Ivax Diagnostics - South Florida Business Journal
Thread abonnieren
